In a first for the bloc, Europe’s Committee for Medicinal Products for Human Use (CHMP) has recommended marketing ...

LLY's blockbuster obesity drugs fuel rapid growth but ABBV's valuation and pipeline may offer safer short-term upside.

And other biotech news brought to you by The Readout.

TAIPEI (Taiwan News) — Far Eastern Memorial Hospital is set to become the first medical institution in Taiwan to administer ...

Jim Rogers, 58, was living and working in Australia when he started to develop symptoms of the incurable neurological ...

Eli Lilly (NYSE:LLY) announced it would appeal a decision by the U.K. health authorities not to recommend the company’s new ...

Microsoft co-founder Bill Gates reflects on his father's Alzheimer's battle and expresses optimism about advancements in ...

And more pharma news updates from Pharmalittle.

A routine medical appointment revealed the first sign of early-onset dementia for Jim Rogers, a 58-year-old British man ...

NEW YORK – The UK's National Institute for Health and Care Excellence on Thursday issued two final guidances, in which it recommended against making Eisai and Biogen's Leqembi (lecanemab) and Eli ...

The re-examination of donanemab, marketed as Kisunla, began on June 2 following a request from Eli Lilly, according to the committee’s monthly meeting highlights on Friday. The committee had ...

Note that some links may require registration or subscription. Three people died and 16 have been hospitalized in a listeria ...